Profil
Roman A. Margolin is currently Director at Clinical Ink, Inc., Director at Granite Global Solutions Holdings, Inc., and Director & Vice President at PSKW Holdings LLC.
Formerly, Mr. Margolin was Director at Netsmart Technologies, Inc. and Cytel, Inc., Managing Director at Genstar Capital Management LLC from 2008 to 2016, Analyst at JPMorgan Securities LLC, and Associate at Willis Stein & Partners from 2004 to 2006.
Education includes an MBA from Stanford University and an undergraduate degree from Case Western Reserve University.
Postes actifs de Roman A. Margolin
| Sociétés | Poste | Début |
|---|---|---|
Granite Global Solutions Holdings, Inc.
Granite Global Solutions Holdings, Inc. Insurance Brokers/ServicesFinance Provides insurance services and risk mitigation solutions | Directeur/Membre du Conseil | - |
PSKW Holdings LLC
PSKW Holdings LLC Financial ConglomeratesFinance Invests in healthcare, therapeutics and diagnostics sectors | Directeur/Membre du Conseil | - |
Clinical Ink, Inc.
Clinical Ink, Inc. Internet Software/ServicesTechnology Services Operates as an eSource platform and provides clinical trial solutions | Directeur/Membre du Conseil | - |
Anciens postes connus de Roman A. Margolin
| Sociétés | Poste | Fin |
|---|---|---|
Genstar Capital Management LLC
Genstar Capital Management LLC Investment ManagersFinance Genstar Capital invests in private and public middle market companies located across the globe. The firm targets companies operating in the fields of financial services, healthcare, software and industrial sectors. It provides financing for corporate carve-outs and buyouts capital transactions. The firm takes a seat on the board of directors and also makes control investments. | Private Equity Investor | 01/01/2016 |
Willis Stein & Partners
Willis Stein & Partners Investment ManagersFinance Willis Stein & Partners seeks to acquire controlling interests in middle-market companies located in the Midwest and across the US. They focus on the following industries: consumer services, education, specialized business services. The firm also has experience investing in healthcare-oriented businesses and they are particularly interested in companies at the intersection of their three focus industries and healthcare. Willis Stein typically invests in industry consolidations, build-ups and management buyouts transactions. The firm seeks to invest up to $350 million per transaction and in transactions valued between $75 million and $750 million. Willis Stein prefers to hold a board in its portfolio companies. The firm seeks to exit their investments in 4 to 7 years through the public markets, recapitalization and/or sale to a strategic buyer. | Analyste en capital-investissement | 31/08/2006 |
Cytel, Inc.
Cytel, Inc. Packaged SoftwareTechnology Services Provides statistical software and analytic services for clinical trials | Directeur/Membre du Conseil | - |
Netsmart Technologies, Inc.
Netsmart Technologies, Inc. Packaged SoftwareTechnology Services Develops and delivers healthcare software and technology solutions | Directeur/Membre du Conseil | - |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Formation de Roman A. Margolin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Netsmart Technologies, Inc.
Netsmart Technologies, Inc. Packaged SoftwareTechnology Services Develops and delivers healthcare software and technology solutions | Technology Services |
Genstar Capital Management LLC
Genstar Capital Management LLC Investment ManagersFinance Genstar Capital invests in private and public middle market companies located across the globe. The firm targets companies operating in the fields of financial services, healthcare, software and industrial sectors. It provides financing for corporate carve-outs and buyouts capital transactions. The firm takes a seat on the board of directors and also makes control investments. | Finance |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Cytel, Inc.
Cytel, Inc. Packaged SoftwareTechnology Services Provides statistical software and analytic services for clinical trials | Technology Services |
Clinical Ink, Inc.
Clinical Ink, Inc. Internet Software/ServicesTechnology Services Operates as an eSource platform and provides clinical trial solutions | Technology Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Willis Stein & Partners
Willis Stein & Partners Investment ManagersFinance Willis Stein & Partners seeks to acquire controlling interests in middle-market companies located in the Midwest and across the US. They focus on the following industries: consumer services, education, specialized business services. The firm also has experience investing in healthcare-oriented businesses and they are particularly interested in companies at the intersection of their three focus industries and healthcare. Willis Stein typically invests in industry consolidations, build-ups and management buyouts transactions. The firm seeks to invest up to $350 million per transaction and in transactions valued between $75 million and $750 million. Willis Stein prefers to hold a board in its portfolio companies. The firm seeks to exit their investments in 4 to 7 years through the public markets, recapitalization and/or sale to a strategic buyer. | Finance |
Granite Global Solutions Holdings, Inc.
Granite Global Solutions Holdings, Inc. Insurance Brokers/ServicesFinance Provides insurance services and risk mitigation solutions | Finance |
PSKW Holdings LLC
PSKW Holdings LLC Financial ConglomeratesFinance Invests in healthcare, therapeutics and diagnostics sectors | Finance |
















